{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:08:36Z","timestamp":1784135316444,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.thromres.2026.109769","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:25:59Z","timestamp":1782372359000},"page":"109769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Direct oral anticoagulants versus vitamin K antagonists for the treatment of cerebral venous thrombosis: A systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"263","author":[{"given":"Maxime","family":"Delrue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Crichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Crassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Le Jeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Frere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109769_bb0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrneurol.2017.104","article-title":"Cerebral venous thrombosis","volume":"13","author":"Silvis","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.thromres.2026.109769_bb0010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ene.13381","article-title":"European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology","volume":"24","author":"Ferro","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.thromres.2026.109769_bb0015","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2026.109769_bb0020","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109769_bb0025","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Hokusai-VTE Investigators","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109769_bb0030","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"EINSTEIN Investigators","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109769_bb0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"AMPLIFY Investigators, Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109769_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040212","article-title":"Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review","volume":"11","author":"Bose","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.thromres.2026.109769_bb0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11239-020-02106-7","article-title":"Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis","volume":"50","author":"Lee","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2026.109769_bb0050","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1161\/STROKEAHA.122.039579","article-title":"Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis","volume":"53","author":"Yaghi","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2026.109769_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ane.13506","article-title":"Safety and efficacy of direct oral anticoagulants in cerebral venous thrombosis: a meta-analysis","volume":"145","author":"Nepal","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.thromres.2026.109769_bb0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjh.18177","article-title":"Efficacy and safety of the direct oral anti-coagulants in patients with cerebral vein thrombosis: a systematic review and meta-analysis","volume":"198","author":"Riva","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2026.109769_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241256360","article-title":"Efficacy and safety of direct oral anticoagulants in cerebral venous thrombosis: meta-analysis of randomized clinical trials","volume":"30","author":"Chen","year":"2024","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109769_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1869","article-title":"Direct oral anticoagulants compared to warfarin in long-term management of cerebral venous thrombosis: a comprehensive meta-analysis","volume":"7","author":"Ranjan","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.thromres.2026.109769_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/10760296251405417","article-title":"Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis of 4,929 patients","volume":"31","author":"Waseem","year":"2025","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109769_bb0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/17474930241234749","article-title":"Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): an open-label, randomized controlled trial","volume":"19","author":"Ma","year":"2024","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.thromres.2026.109769_bb0085","article-title":"Rivaroxaban versus warfarin for the treatment of cerebral venous thrombosis (RWCVT): a randomized controlled trial in resource-limited setting","volume":"2025","author":"Alkhawam","year":"2025","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.thromres.2026.109769_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.thromres.2026.109769_bb0095","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109769_bb0100","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109769_bb0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.thromres.2026.109769_bb0110","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (Updated August 2024)","year":"2024"},{"key":"10.1016\/j.thromres.2026.109769_bb0115","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/jamaneurol.2019.2764","article-title":"Safety and efficacy of dabigatran etexilate vs. dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial","volume":"76","author":"Ferro","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.thromres.2026.109769_bb0120","first-page":"125","article-title":"Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: a case-control blinded study","volume":"20","author":"Khorvash","year":"2021","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.thromres.2026.109769_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21556660.2020.1838769","article-title":"Use of oral rivaroxaban in cerebral venous thrombosis","volume":"10","author":"Maqsood","year":"2020","journal-title":"J. Drug Assess."},{"key":"10.1016\/j.thromres.2026.109769_bb0130","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1161\/STROKEAHA.123.044113","article-title":"Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis","volume":"54","author":"Field","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2026.109769_bb0135","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/STROKEAHA.121.037541","article-title":"Direct oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): a multicenter international study","volume":"53","author":"Yaghi","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2026.109769_bb0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1474-4422(24)00519-2","article-title":"Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study","volume":"24","author":"van de Munckhof","year":"2025","journal-title":"Lancet Neurol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482600188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482600188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:44:45Z","timestamp":1784133885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482600188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"alternative-id":["S004938482600188X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109769","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants versus vitamin K antagonists for the treatment of cerebral venous thrombosis: A systematic review and meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109769"}}